■ 一周谈 曾经在一年前进入证监会14家企业预披露名单的步长制药，时隔一年之后开启二次IPO之旅。作为国内中成药领军企业之一，步长制药去年的招股说明书显示，2011年至2014年连续三年利润超10亿元，在2013年度中国制药工业百强榜中，步长制药位列本土制药工业第八名。单就财务数据而...
One week talked about the step-size pharmaceuticals that entered the pre-disclosed list of 14 companies a year ago and started a second IPO a year later. As one of the leading Chinese patent medicine companies, Steps Pharmaceuticals last year's prospectus shows that its profits exceeded 1 billion yuan for three consecutive years from 2011 to 2014. Steps Pharmaceuticals ranked eighth among the top 100 Chinese pharmaceutical industries in 2013. Solely on financial data and...
